REOCCURENCE XERODERMA PIGMENTOSUM WITHIN ONE GENERATION

Dhany Prafita Ekasari

Abstract


Xeroderma Pigmentosum (XP) is caused by impaired repair of DNA defects induced by ultraviolet (UV) radiation and is inherited in an autosomal recessive manner. Consanguinity is the main etiological factor of XP and an important factor in autosomal recessive diseases. Clinical symptoms of XP can be cutaneous and non-cutaneous. The patient was a 2-year-old boy with complaints of dark spots on the face to both arms since 6 months of age that increased in number within 1.5 years. The patient's older sibling had XP. The patient also had complaints of red eyes and glare since 1 year ago. Dermatological examination of the facial region and superior extremities dextra and sinistra revealed hyperpigmented macules and patches, multiple, well-defined, regular margins, variable in shape and size. Physical examination of the eyes revealed neovascularisation and conjunctivalisation and diagnosed as ODS Limbal Stem Cell Deficiency. The patient was treated with sunscreen with 30 SPF and olium olivarum 2 dd ue on dry areas. Levofloxacin eye drops were given to both eyes. There was no familial relationship between the patient's parents. Based on the inheritance pattern of autosomal recessive disease, the patient's parents are suspected to be XP carriers, increasing the possibility (>25%) of XP in their offspring. Comprehensive counselling regarding hereditary genetic diseases and marital history from several different generations should be done to prevent the occurrence of XP in the offspring.

Keywords


xeroderma pigmentosum, autosomal recessive

Full Text:

PDF

References


Black JO. Xeroderma Pigmentosum. Head Neck Pathol. 2016 Jun 14;10(2):139–44.

Brambullo T, Colonna MR, Vindigni V, Piaserico S, Masciopinto G, Galeano M, et al. Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated—A Systematic Review. Biomed Res Int. 2022;2022.

Effendi RMRA, Fadhlih A, Diana IA, Gondokaryono SP, Dwiyana RF. Xeroderma Pigmentosum with Simultaneous Cutaneous and Ocular Squamous Cell Carcinoma. Clin Cosmet Investig Dermatol. 2022 Feb;Volume 15:157–61.

Darr A, Small N, Ahmad WIU, Atkin K, Corry P, Modell B. Addressing key issues in the consanguinity-related risk of autosomal recessive disorders in consanguineous communities: lessons from a qualitative study of British Pakistanis. J Community Genet. 2016 Jan 12;7(1):65–79.

Gulani A, Weiler T. Genetics, Autosomal Recessive. StatPearls Publishing; 2023

Yuniati R, Sihombing NRB, Nauphar D, Tiawarman B, Kartikasari DS, Dewi M, et al. Clinical manifestation and genetic analysis of familial rare disease genodermatosis xeroderma pigmentosum. Intractable Rare Dis Res. 2021 May 31;10(2):114–21.

Nishigori C, Nakano E, Masaki T, Ono R, Takeuchi S, Tsujimoto M, et al. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care. Photochem Photobiol. 2019 Jan;95(1):140–53.

Le Q, Xu J, Deng SX. The diagnosis of limbal stem cell deficiency. Ocul Surf. 2018 Jan;16(1):58–69.

Chidzonga MM, Mahomva L, Makunike-Mutasa R, Masanganise R. Xeroderma Pigmentosum: A Retrospective Case Series in Zimbabwe. Journal of Oral and Maxillofacial Surgery. 2009 Jan;67(1):22–31.

Martens MC, Emmert S, Boeckmann L. Xeroderma Pigmentosum: Gene Variants and Splice Variants. Genes (Basel). 2021 Jul 29;12(8):1173.

Piccione M, Belloni Fortina A, Ferri G, Andolina G, Beretta L, Cividini A, et al. Xeroderma Pigmentosum: General Aspects and Management. J Pers Med. 2021 Nov 4;11(11):1146.

Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Xeroderma pigmentosum: an updated review. Drugs Context. 2022 Apr 25;11:1–17.

Icha Aisyah N, Afif Nurul Hidayati N. Case Report: Developed Infraocular Squamous Cell Carcinoma and Nasal Basal Cell Carcinoma in Xeroderma Pigmentosum. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2018;30(2):171–7.

Suhas N MC, Rashmi Agarwal J. Xeroderma Pigmentosum: A Case Report of Two Siblings. J immunodefic Disord. 2012;01(02).

Ortega-Recalde O, Vergara JI, Fonseca DJ, Ríos X, Mosquera H, Bermúdez OM, et al. Whole-Exome Sequencing Enables Rapid Determination of Xeroderma Pigmentosum Molecular Etiology. PLoS One. 2013 Jun 3;8(6):e64692.

Bhutto AM, Shaikh A, Nonaka S. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study. British Journal of Dermatology. 2005 Mar;152(3):545–51.

Fernandes M, Sangwan VS, Vemuganti GK. Limbal stem cell deficiency and xeroderma pigmentosum: a case report. Eye. 2004 Jul 7;18(7):741–3.

Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum. Orphanet J Rare Dis. 2011;6(1):70.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.